BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2412683)

  • 1. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
    Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
    Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
    Pizzocaro G; Pasi M; Salvioni R; Zanoni F; Milani A; Piva L
    Cancer; 1985 Nov; 56(10):2399-403. PubMed ID: 2412681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
    Pinkerton CR; Pritchard J; Spitz L
    J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
    Pizzocaro G; Zanoni F; Milani A; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
    Cancer; 1984 Mar; 53(6):1363-8. PubMed ID: 6198070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
    Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
    Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
    McKendrick JJ; Mead GM; Cowlishaw D
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current therapeutic orientation toward testicular germ cell tumors].
    Catani M; De Milito R; Chiaretti M; Cortesi E; Anselmi W; Manili G; Tomei B; Terrinoni V; Bianchi G; Rengo M
    Minerva Urol Nefrol; 1999 Jun; 51(2):113-7. PubMed ID: 10429422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
    Curigliano G; Spitaleri G; Magni E; Lorizzo K; De Cobelli O; Locatelli M; Fumagalli L; Adamoli L; Cossu Rocca M; Verri E; De Pas T; Jereczek-Fossa B; Martinelli G; Goldhirsch A; Nolè F
    J Chemother; 2009 Dec; 21(6):687-92. PubMed ID: 20071294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
    Bassoulet J; Raoul Y; Garetta L
    Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testis.
    Germá Lluch JR; Seguí Palmer MA; Climent Durán MA; Blanco Guerrero R; Fernández Sagarra A; Villavicencio H; Solé Balcells FJ
    Eur Urol; 1992; 21(4):287-93. PubMed ID: 1333957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report.
    Iida K; Naiki T; Kawai N; Ando R; Etani T; Tozawa K; Kohri K
    BMC Res Notes; 2014 Dec; 7():865. PubMed ID: 25444462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.